Rhabdomyosarcoma
Rhabdomyosarcoma is a rare type of cancer that develops from soft tissue, often affecting children and adolescents. It can occur in various parts of the body, including the head, neck, and limbs.
Lutetium Lu 177 Edotreotide for Pediatric Tumors
We are studying a new targeted therapy for children with somatostatin receptor-positive tumors to find the right dose and evaluate its safety. This trial will also look at how well the treatment works compared to standard care.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Lymphoma
Lymphoma is a type of cancer that affects the lymphatic system, which is part of the immune system. It can cause swollen lymph nodes, fever, weight loss, and night sweats.
Neuroendocrine Tumor
Neuroendocrine tumors are a group of rare tumors that arise from neuroendocrine cells, which can be found throughout the body. They can affect hormone production and cause various symptoms depending on their location.
Central Nervous System Neoplasm
Central nervous system neoplasms are tumors that occur in the brain or spinal cord. They can be benign or malignant and may cause neurological symptoms.
Peripheral Primitive Neuroectodermal Tumor
Peripheral primitive neuroectodermal tumors are aggressive cancers that typically occur in soft tissues and bones, primarily in children and young adults.
Gastrointestinal Stromal Tumor
Gastrointestinal stromal tumors are rare tumors found in the digestive tract, often in the stomach or small intestine. They can cause abdominal pain and other digestive issues.
Ewing's Sarcoma
Ewing's sarcoma is a type of bone cancer that primarily affects children and young adults, often occurring in the pelvis, legs, or arms.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 24 months and 18 years old?
- Do you have a confirmed diagnosis of a neuroendocrine tumor or other specified tumors?
- Have you had any chemotherapy or radiation treatment in the past 4 weeks?
- Are you currently pregnant or breastfeeding?
- Do you have any severe kidney or liver problems?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Arginine-Lysine
Lutetium Edotreotide
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Centre Hospitalier Regional De Marseille
Service d’Immunologie, Hématologie et oncologie pédiatrique
Marseille, France
Institut Gustave Roussy
Medecine oncologique
Villejuif, France
Fondazione IRCCS Istituto Nazionale Dei Tumori
#1030201: S.C. Pediatria Oncologica
Milan, Italy
Sponsor: ITM Solucin GmbH
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.